UK markets closed

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0900-0.0800 (-2.52%)
At close: 01:00PM EST
3.2400 +0.15 (+4.85%)
After hours: 03:54PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 525.82M
Enterprise value 236.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.15k
Price/book (mrq)1.82
Enterprise value/revenue 557.10
Enterprise value/EBITDA -1.63

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-71.88%
S&P500 52-week change 3-13.51%
52-week high 311.9200
52-week low 32.6000
50-day moving average 33.1175
200-day moving average 34.1204

Share statistics

Avg vol (3-month) 3837.32k
Avg vol (10-day) 31.53M
Shares outstanding 5165.88M
Implied shares outstanding 6N/A
Float 8137.46M
% held by insiders 19.28%
% held by institutions 134.95%
Shares short (14 Nov 2022) 44.75M
Short ratio (14 Nov 2022) 44.73
Short % of float (14 Nov 2022) 43.61%
Short % of shares outstanding (14 Nov 2022) 42.87%
Shares short (prior month 13 Oct 2022) 46.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-34,233.88%

Management effectiveness

Return on assets (ttm)-22.00%
Return on equity (ttm)-53.78%

Income statement

Revenue (ttm)425k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)20.38M
EBITDA -145.35M
Net income avi to common (ttm)-196.25M
Diluted EPS (ttm)-1.3990
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)304.06M
Total cash per share (mrq)1.83
Total debt (mrq)17.1M
Total debt/equity (mrq)5.78
Current ratio (mrq)12.25
Book value per share (mrq)1.75

Cash flow statement

Operating cash flow (ttm)-94.47M
Levered free cash flow (ttm)-40.55M